Enliven Therapeutics, Inc.
2023 Q2 - 2025 Q4 (11 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 140 | 0.0% | 9,097 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 309 | 0.0% | 15,097 | 9/30/2025 |
| 2025 Q2 | 10/8/2025 | 197 | 0.0% | 9,797 | 6/30/2025 |
| 2025 Q1 | 10/8/2025 | 193 | 0.0% | 9,797 | 3/31/2025 |
| 2024 Q4 | 10/8/2025 | 563 | 0.0% | 25,023 | 12/31/2024 |
| 2024 Q3 | 10/8/2025 | 703 | 0.0% | 27,511 | 9/30/2024 |
| 2024 Q2 | 10/8/2025 | 541 | 0.0% | 23,170 | 6/30/2024 |
| 2024 Q1 | 10/8/2025 | 165 | 0.0% | 9,375 | 3/31/2024 |
| 2023 Q4 | 10/8/2025 | 130 | 0.0% | 9,399 | 12/31/2023 |
| 2023 Q3 | 10/8/2025 | 129 | 0.0% | 9,453 | 9/30/2023 |
| 2023 Q2 | 10/8/2025 | 188 | 0.0% | 9,200 | 6/30/2023 |